The patient blood management market size has grown marginally in recent years. It will grow from $15.94 billion in 2025 to $15.95 billion in 2026 at a compound annual growth rate (CAGR) of 0.1%. The growth in the historic period can be attributed to rising surgical volumes, blood supply shortages, transfusion-related complications awareness, hospital cost containment pressure, clinical guideline standardization.
The patient blood management market size is expected to see strong growth in the next few years. It will grow to $22.98 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to aging population growth, elective surgery growth, stricter transfusion regulations, value-based healthcare adoption, expansion of pbm in emerging markets. Major trends in the forecast period include preoperative anemia screening protocols, point-of-care hemoglobin testing, standardized transfusion guidelines adoption, multidisciplinary PBM programs in hospitals, increased clinician education on PBM.
The increasing number of surgical procedures is increasingly supporting the expansion of the patient blood management market going forward. Surgical procedures involve the physical manipulation of tissues or organs to diagnose, treat, or prevent medical conditions and often require incisions and specialized instruments. The growth in surgical volumes is linked to the rising prevalence of chronic diseases, advancements in medical technology, improved surgical techniques, and aging populations. Patient blood management enhances surgical care by optimizing blood utilization, reducing the need for transfusions, minimizing complications, and improving outcomes through effective anemia management and preoperative assessment. For example, in August 2023, according to The Aesthetic Society, a US-based organization representing plastic surgery and cosmetic medicine professionals, Americans spent over $11.8 billion on aesthetic procedures, reflecting a 2% increase compared to 2022. Consequently, the growing number of surgical procedures is contributing to the expansion of the patient blood management market.
Leading companies operating in the patient blood management market are focusing on innovative medical devices for blood transfusions to strengthen market revenues. Blood transfusion devices are designed to safely and efficiently collect, process, and deliver blood products to patients. For example, in May 2024, Becton, Dickinson, and Company launched UltraTouch, a device engineered to simplify blood sample collection while minimizing patient discomfort. The device enables efficient venipuncture, improves sample accuracy, incorporates ergonomic design features, and includes safety mechanisms to reduce needle-stick injuries, enhancing both patient and clinician experience.
In December 2024, GVS S.p.A., an Italy-based medical device and filtration company, acquired the transfusion medicine business of Haemonetics Corporation. Through this acquisition, GVS seeks to strengthen its position in the healthcare filtration sector and expand its global footprint by integrating Haemonetics’ proprietary solutions for blood collection, processing, filtration, and transfusion. Haemonetics Corporation is a US-based company specializing in transfusion medicine and blood management solutions.
Major companies operating in the patient blood management market are Haemonetics Corporation, Fresenius SE & Co. KGaA, Terumo Corporation, Immucor Inc., B. Braun Melsungen AG, Macopharma, bioMérieux SA, Asahi Kasei Corporation, KANEKA CORPORATION, Bio-Rad Laboratories Inc, Abbott Laboratories, Grifols, Roche, LIVANOVA PLC, Danaher, Mediware information systems, Kawasumi Laboratories, Haier Biomedical, Diatron MI Zrt., BAG Diagnostics GmbH, Hitachi Ltd., Ortho Clinical Diagnostics, Beckman Coulter Inc., Siemens Healthineers, Thermo Fisher Scientific Inc., Sysmex Corporation, Nihon Kohden Corporation, Radiometer Medical ApS, Instrumentation Laboratory, F. Hoffmann-La Roche Ltd, Grifols Diagnostic Solutions Inc., HemoCue AB.
North America was the largest region in the patient blood management market in 2025. Western Europe was the second-largest region in the patient blood management market share. The regions covered in the patient blood management market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the patient blood management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have moderately impacted the patient blood management market by increasing costs for imported instruments, reagents, and software systems used in blood monitoring and diagnostics. Hospitals in asia-pacific and latin america relying on imported blood management devices face procurement delays and higher pricing, particularly across instruments and reagents segments. However, tariffs are encouraging domestic manufacturing, local sourcing, and regional partnerships, which may strengthen supply resilience and cost optimization over the long term.
The patient blood management market research report is one of a series of new reports that provides patient blood management market statistics, including patient blood management industry global market size, regional shares, competitors with a patient blood management market share, detailed patient blood management market segments, market trends and opportunities, and any further data you may need to thrive in the patient blood management industry. This patient blood management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Patient blood management is a patient-centered, evidence-based, and systematic approach to improving the care of individuals who may require a blood transfusion by optimizing the patient’s blood levels, reducing surgical blood loss, and utilizing the body’s physiological tolerance to anemia, thereby decreasing the need for donated blood transfusions.
The patient blood management market is segmented by product into instruments, accessories, reagents and kits, and software solutions. Patient blood management kits are used to optimize and manage a patient’s blood resources. The market is further segmented by component into plasma, whole blood, and red blood cells, which are used across applications such as hospitals, clinics, and others.
The patient blood management market includes revenues earned by instruments, blood processing devices, and centrifuges. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The patient blood management market size is expected to see strong growth in the next few years. It will grow to $22.98 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to aging population growth, elective surgery growth, stricter transfusion regulations, value-based healthcare adoption, expansion of pbm in emerging markets. Major trends in the forecast period include preoperative anemia screening protocols, point-of-care hemoglobin testing, standardized transfusion guidelines adoption, multidisciplinary PBM programs in hospitals, increased clinician education on PBM.
The increasing number of surgical procedures is increasingly supporting the expansion of the patient blood management market going forward. Surgical procedures involve the physical manipulation of tissues or organs to diagnose, treat, or prevent medical conditions and often require incisions and specialized instruments. The growth in surgical volumes is linked to the rising prevalence of chronic diseases, advancements in medical technology, improved surgical techniques, and aging populations. Patient blood management enhances surgical care by optimizing blood utilization, reducing the need for transfusions, minimizing complications, and improving outcomes through effective anemia management and preoperative assessment. For example, in August 2023, according to The Aesthetic Society, a US-based organization representing plastic surgery and cosmetic medicine professionals, Americans spent over $11.8 billion on aesthetic procedures, reflecting a 2% increase compared to 2022. Consequently, the growing number of surgical procedures is contributing to the expansion of the patient blood management market.
Leading companies operating in the patient blood management market are focusing on innovative medical devices for blood transfusions to strengthen market revenues. Blood transfusion devices are designed to safely and efficiently collect, process, and deliver blood products to patients. For example, in May 2024, Becton, Dickinson, and Company launched UltraTouch, a device engineered to simplify blood sample collection while minimizing patient discomfort. The device enables efficient venipuncture, improves sample accuracy, incorporates ergonomic design features, and includes safety mechanisms to reduce needle-stick injuries, enhancing both patient and clinician experience.
In December 2024, GVS S.p.A., an Italy-based medical device and filtration company, acquired the transfusion medicine business of Haemonetics Corporation. Through this acquisition, GVS seeks to strengthen its position in the healthcare filtration sector and expand its global footprint by integrating Haemonetics’ proprietary solutions for blood collection, processing, filtration, and transfusion. Haemonetics Corporation is a US-based company specializing in transfusion medicine and blood management solutions.
Major companies operating in the patient blood management market are Haemonetics Corporation, Fresenius SE & Co. KGaA, Terumo Corporation, Immucor Inc., B. Braun Melsungen AG, Macopharma, bioMérieux SA, Asahi Kasei Corporation, KANEKA CORPORATION, Bio-Rad Laboratories Inc, Abbott Laboratories, Grifols, Roche, LIVANOVA PLC, Danaher, Mediware information systems, Kawasumi Laboratories, Haier Biomedical, Diatron MI Zrt., BAG Diagnostics GmbH, Hitachi Ltd., Ortho Clinical Diagnostics, Beckman Coulter Inc., Siemens Healthineers, Thermo Fisher Scientific Inc., Sysmex Corporation, Nihon Kohden Corporation, Radiometer Medical ApS, Instrumentation Laboratory, F. Hoffmann-La Roche Ltd, Grifols Diagnostic Solutions Inc., HemoCue AB.
North America was the largest region in the patient blood management market in 2025. Western Europe was the second-largest region in the patient blood management market share. The regions covered in the patient blood management market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the patient blood management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have moderately impacted the patient blood management market by increasing costs for imported instruments, reagents, and software systems used in blood monitoring and diagnostics. Hospitals in asia-pacific and latin america relying on imported blood management devices face procurement delays and higher pricing, particularly across instruments and reagents segments. However, tariffs are encouraging domestic manufacturing, local sourcing, and regional partnerships, which may strengthen supply resilience and cost optimization over the long term.
The patient blood management market research report is one of a series of new reports that provides patient blood management market statistics, including patient blood management industry global market size, regional shares, competitors with a patient blood management market share, detailed patient blood management market segments, market trends and opportunities, and any further data you may need to thrive in the patient blood management industry. This patient blood management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Patient blood management is a patient-centered, evidence-based, and systematic approach to improving the care of individuals who may require a blood transfusion by optimizing the patient’s blood levels, reducing surgical blood loss, and utilizing the body’s physiological tolerance to anemia, thereby decreasing the need for donated blood transfusions.
The patient blood management market is segmented by product into instruments, accessories, reagents and kits, and software solutions. Patient blood management kits are used to optimize and manage a patient’s blood resources. The market is further segmented by component into plasma, whole blood, and red blood cells, which are used across applications such as hospitals, clinics, and others.
The patient blood management market includes revenues earned by instruments, blood processing devices, and centrifuges. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Patient Blood Management Market Characteristics
3. Patient Blood Management Market Supply Chain Analysis
4. Global Patient Blood Management Market Trends and Strategies
5. Patient Blood Management Market Analysis of End Use Industries
7. Global Patient Blood Management Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Patient Blood Management Total Addressable Market (TAM) Analysis for the Market
9. Patient Blood Management Market Segmentation
10. Patient Blood Management Market Regional and Country Analysis
11. Asia-Pacific Patient Blood Management Market
12. China Patient Blood Management Market
13. India Patient Blood Management Market
14. Japan Patient Blood Management Market
15. Australia Patient Blood Management Market
16. Indonesia Patient Blood Management Market
17. South Korea Patient Blood Management Market
18. Taiwan Patient Blood Management Market
19. South East Asia Patient Blood Management Market
20. Western Europe Patient Blood Management Market
21. UK Patient Blood Management Market
22. Germany Patient Blood Management Market
23. France Patient Blood Management Market
24. Italy Patient Blood Management Market
25. Spain Patient Blood Management Market
26. Eastern Europe Patient Blood Management Market
27. Russia Patient Blood Management Market
28. North America Patient Blood Management Market
29. USA Patient Blood Management Market
30. Canada Patient Blood Management Market
31. South America Patient Blood Management Market
32. Brazil Patient Blood Management Market
33. Middle East Patient Blood Management Market
34. Africa Patient Blood Management Market
36. Patient Blood Management Market Competitive Landscape and Company Profiles
37. Patient Blood Management Market Other Major and Innovative Companies
40. Patient Blood Management Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Patient Blood Management Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses patient blood management market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for patient blood management? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The patient blood management market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Instruments; Accessories; Reagents And Kits; Software2) By Component: Plasma; Whole Blood; Red Blood Cells
3) By Application: Hospital; Clinic; Other Applications
Subsegments:
1) By Instruments: Blood Collection Devices; Blood Processing Devices; Blood Transfusion Devices2) By Accessories: Blood Bags; Transfer Sets; Filters
3) By Reagents And Kits: Blood Typing Reagents; Coagulation Test Kits; Hemoglobin Test Kits
4) By Software: Blood Management Information Systems; Data Management Software; Inventory Management Software
Companies Mentioned: Haemonetics Corporation; Fresenius SE & Co. KGaA; Terumo Corporation; Immucor Inc.; B. Braun Melsungen AG; Macopharma; bioMérieux SA; Asahi Kasei Corporation; KANEKA CORPORATION; Bio-Rad Laboratories Inc; Abbott Laboratories; Grifols; Roche; LIVANOVA PLC; Danaher; Mediware information systems; Kawasumi Laboratories; Haier Biomedical; Diatron MI Zrt.; BAG Diagnostics GmbH; Hitachi Ltd.; Ortho Clinical Diagnostics; Beckman Coulter Inc.; Siemens Healthineers; Thermo Fisher Scientific Inc.; Sysmex Corporation; Nihon Kohden Corporation; Radiometer Medical ApS; Instrumentation Laboratory; F. Hoffmann-La Roche Ltd; Grifols Diagnostic Solutions Inc.; HemoCue AB
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Patient Blood Management market report include:- Haemonetics Corporation
- Fresenius SE & Co. KGaA
- Terumo Corporation
- Immucor Inc.
- B. Braun Melsungen AG
- Macopharma
- bioMérieux SA
- Asahi Kasei Corporation
- KANEKA CORPORATION
- Bio-Rad Laboratories Inc
- Abbott Laboratories
- Grifols
- Roche
- LIVANOVA PLC
- Danaher
- Mediware information systems
- Kawasumi Laboratories
- Haier Biomedical
- Diatron MI Zrt.
- BAG Diagnostics GmbH
- Hitachi Ltd.
- Ortho Clinical Diagnostics
- Beckman Coulter Inc.
- Siemens Healthineers
- Thermo Fisher Scientific Inc.
- Sysmex Corporation
- Nihon Kohden Corporation
- Radiometer Medical ApS
- Instrumentation Laboratory
- F. Hoffmann-La Roche Ltd
- Grifols Diagnostic Solutions Inc.
- HemoCue AB
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 15.95 Billion |
| Forecasted Market Value ( USD | $ 22.98 Billion |
| Compound Annual Growth Rate | 9.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 33 |
